AssetMark Inc’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-13,538
| Closed | -$590K | – | 2024 |
|
|
2023
Q3 | $590K | Buy |
13,538
+5,717
| +73% | +$249K | ﹤0.01% | 725 |
|
|
2023
Q2 | $283K | Buy |
7,821
+1,600
| +26% | +$57.8K | ﹤0.01% | 794 |
|
|
2023
Q1 | $231K | Buy |
6,221
+902
| +17% | +$33.5K | ﹤0.01% | 811 |
|
|
2022
Q4 | $241K | Buy |
5,319
+2,705
| +103% | +$123K | ﹤0.01% | 793 |
|
|
2022
Q3 | $183K | Buy |
2,614
+1,008
| +63% | +$70.6K | ﹤0.01% | 774 |
|
|
2022
Q2 | $108K | Buy |
1,606
+1,422
| +773% | +$95.6K | ﹤0.01% | 813 |
|
|
2022
Q1 | $15K | Buy |
+184
| New | +$15K | ﹤0.01% | 1133 |
|